Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Asia-Pacific Consensus Statements on Crohn's disease. Part 2: Management

Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei SC, Leung WK, Koh PK, Gearry RB, Goh KL, Ouyang Q, Sollano J, Manatsathit S, de Silva HJ, Rerknimitr R, Pisespongsa P, Abu Hassan MR, Sung J, Hibi T, Boey CC, Moran N

(2016), J Gastroenterol Hepatol, 31(1),

Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus-Part 1)

Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei SC, Leung WK, Koh PK, Gearry RB, Goh KL, Ouyang Q, Sollano J, Manatsathit S, de Silva HJ, Rerknimitr R, Pisespongsa P, Abu Hassan MR, Sung J, Hibi T, Boey CC, Moran N

(2016), J Gastroenterol Hepatol, 31(1),

High-dose vitamin D supplementation and liver histology in NASH

Kitson MT, Pham A, Gordon A, Kemp W, Roberts SK

(2016), Gut, 65(4),

Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?

De Giorgio R, Volta U, Gibson PR

(2016), Gut, 65(1),

Review article: insights into colonic protein fermentation, its modulation and potential health implications

Yao CK, Muir JG, Gibson PR

(2016), Aliment Pharmacol Ther, 43(2),

B-cell dysregulation in Crohn's disease is partially restored with infliximab therapy

Timmermans WM, van Laar JA, van der Houwen TB, Kamphuis LS, Bartol SJ, Lam KH, Ouwendijk RJ, Sparrow MP, Gibson PR, van Hagen PM, van Zelm MC

(2016), PLoS One, 11(7),

A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis

Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR

(2016), Aliment Pharmacol Ther, 43(9),

Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities

Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR

(2016), Aliment Pharmacol Ther, 44(3),

Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome

Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR

(2016), Aliment Pharmacol Ther, 44(5),

Potential of in vivo real-time gastric gas profiling: a pilot evaluation of heat-stress and modulating dietary cinnamon effect in an animal model

Ou JZ, Cottrell JJ, Ha N, Pillai N, Yao CK, Berean KJ, Ward SA, Grando D, Muir JG, Harrison CJ, Wijesiriwardana U, Dunshea FR, Gibson PR, Kalantar-Zadeh K

(2016), Sci Rep, 6,

Uncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disorders

Linedale EC, Chur-Hansen A, Mikocka-Walus A, Gibson PR, Andrews JM

(2016), Clin Gastroenterol Hepatol, 14(12),

Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection

Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, Bibby BM, Uldbjerg N, Connell WR, Rosella O, Grosen A, Brown SJ, Kjeldsen J, Wildt S, Svenningsen L, Sparrow MP, Walsh A, Connor SJ, Radford-Smith G, Lawrance IC, Andrews JM, Ellar

(2016), Gastroenterology, 151(1),

Intestinal gas capsules: a proof-of-concept demonstration

Kalantar-Zadeh K, Yao CK, Berean KJ, Ha N, Ou JZ, Ward SA, Pillai N, Hill J, Cottrell JJ, Dunshea FR, McSweeney C, Muir JG, Gibson PR

(2016), Gastroenterology, 150(1),

Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn's disease: a randomised, controlled cross-over trial of well-defined diets

Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR

(2016), Clin Transl Gastroenterol, 7,

Maintenance of efficacy and continuing safety of golimumab for active ulcerative colitis: PURSUIT-SC maintenance study extension through 1 year

Gibson PR, Feagan BG, Sandborn WJ, Marano C, Strauss R, Johanns J, Padgett L, Collins J, Tarabar D, Hebzda Z, Rutgeerts P, Reinisch W

(2016), Clin Transl Gastroenterol, 7,

Faecal calprotectin: current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists

Elnawsra O, Fok I, Sparrow M, Gibson P, Andrews J, Connor S

(2016), Intern Med J, 46(5),

The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis

Varney JE, Liew D, Weiland TJ, Inder WJ, Jelinek GA

(2016), BMC Health Serv Res, 16,

Safety of rapid infusion of iron polymaltose: comparative study in 300 patients

Chan PTY, Corallo CE, Dooley MJ, Poole SG, Gibson PR

(2016), J Pharm Pract Res, 46(4),

A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol

Papamiltiadous ES, Roberts SK, Nicoll AJ, Ryan MC, Itsiopoulos C, Salim A, Tierney AC

(2016), BMC Gastroenterol, 16,

Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis

Kao JH, Jensen DM, Manns MP, Jacobson I, Kumada H, Toyota J, Heo J, Yoffe B, Sievert W, Bessone F, Peng CY, Roberts SK, Lee YJ, Bhore R, Mendez P, Hughes E, Noviello S

(2016), Liver Int, 36(7),

10 11 12 13 14